Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Ordinary shares, nominal value $0.01 per share
-
Shares outstanding
-
17,255,853
-
Total 13F shares
-
12,091,447
-
Share change
-
-1,243,361
-
Total reported value
-
$59,125,821
-
Price per share
-
$4.89
-
Number of holders
-
93
-
Value change
-
-$7,352,003
-
Number of buys
-
28
-
Number of sells
-
84
Institutional Holders of Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) as of Q1 2024
As of 31 Mar 2024,
Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,091,447 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, WESTFIELD CAPITAL MANAGEMENT CO LP, BlackRock Inc., VANGUARD GROUP INC, Verition Fund Management LLC, Solas Capital Management, LLC, Alta Fundamental Advisers LLC, Newtyn Management, LLC, Prosight Management, LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
94
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.